Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenon vs sevoflurane for prevention of postoperative delirium in elderly hip fracture surgery
2009-017153-35Phase 2Completed
- Sponsor
- Air Liquide Healthcare
- Start
- Feb 2010
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of xenon in postoperative delirium (POD) and hip fracture (2 arms), sponsored by Air Liquide Healthcare. Primary endpoint: Post-operative delirium incidence within 4 days. Started Feb 2010; status: completed.
02
Drugs
xenon
03
Conditions
postoperative delirium (POD)hip fracture
Beyond the preview
Go deeper on 2009-017153-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017153-35.